Bristol Myers makes $11 billion deal with BioNTech to join the cancer-drug race

Bristol-Myers makes an $11 billion deal with BioNTech to join the new cancer-treatment game, nearly double the size of Pfizer’s deal announced two weeks earlier.

Source: MarketWatch

Continue reading...